Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral Methylprednisolone Taper Following Primary TKA
NCT07070882Phase 1Active, not recruiting
- Sponsor
- Columbia University
- Start
- Jun 2025
- Primary completion
- Dec 2025
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, randomised, single-blind trial of methylprednisolone in postoperative pain and postoperative nausea and vomiting (PONV) (2 arms), sponsored by Columbia University. Primary endpoint: Mean postoperative pain. Started Jun 2025; status: active, not recruiting.
02
Drugs
methylprednisolone
03
Conditions
postoperative painpostoperative nausea and vomiting (PONV)
Beyond the preview
Go deeper on NCT07070882.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07070882.